New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For A;R;SPW;SNY;WBMD;CVS;ESV;TER;BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
January 15, 2015
07:13 EDTWBMDJPMorgan to hold a conference
Subscribe for More Information
January 13, 2015
11:14 EDTCVSCVS Health repeats FY15 adjusted EPS view $5.05-$5.19, consensus $5.13
CVS Health repeats forecast for FY15 revenue growth of 7%-8.25%, consensus $148.9B. CVS Health repeats forecast for FY15 free cash flow $5.9B-$6.2B. Previously issued FY15 guidance repeated in slides for JPMorgan Healthcare Conference presentation.
11:11 EDTCVSCVS Health says gaining share in growing Rx market
Subscribe for More Information
07:42 EDTCVSJPMorgan to hold a conference
33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link
07:36 EDTWBMDWebMD sees Private Portals revenue growth in mid-single digits in 2015
Subscribe for More Information
07:36 EDTWBMDWebMD sees Q4, FY14 revenue, adjusted EBITDA at high end of prior ranges
On November 5, WebMD Health issued a press release that, among other things, provided financial guidance for Q4nd the year ending December 31, 2014. The financial guidance for FY14 included a range for revenue of $570M-$580M and a range for adjusted EBITDA of $152.5M-$157.5M. WebMD plans to indicate, at an investor conference this week, that revenue and Adjusted EBITDA for the quarter and year ended December 31, 2014 are expected to be at the high end of the ranges provided ion November 5. FY14 revenue consensus is $577.37M.
January 12, 2015
10:00 EDTTEROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTADako, Cell Signaling Technology announce partnership
Dako, an Agilent Technologies company, and Cell Signaling Technology, or CST, a worldwide provider of antibodies, announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. The financial details of the agreement were not disclosed.
09:04 EDTAAgilent's Dako unit, Cell Signaling Technology announce strategic partnership
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. The financial details of the agreement were not disclosed.
08:37 EDTSNYShire deal suggests most biotech companies in play, says JMP Securities
After Shire (SHPG) agreed to buy NPS Pharmaceuticals (NPSP), JMP Securities says the deal indicates that most biotech companies are in play, particularly those with worldwide rights to their products for well-defined patient populations. The firm expects investors to speculate all week about potential new targets in the space. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06:57 EDTTERTeradyne downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use